BNDW vs IBB

Vanguard Total World Bond ETF vs iShares Biotechnology ETF

Quick take
  • • BNDW has the lower expense ratio at 0.05% vs 0.44% for IBB.
  • • BNDW pays a higher dividend yield (4.36%).

Side-by-side metrics

MetricBNDWIBB
Expense ratio
Annual fee. Lower is better.
0.05%0.44%
Dividend yield
Trailing 12-month yield.
4.36%0.16%
AUM
Assets under management — bigger funds are typically more liquid.
$1.93B$11.50B
YTD return
0.46%30.22%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.810.60
P/E ratio
—25.48
Last price
$66.72$217.75
Inception
——
Issuer
VanguardiShares

BNDW top holdings

Top holdings · BNDW
BNDVanguard Total Bond Market ETF51.31%
BNDXVanguard Total International Bond ETF48.69%
Sector breakdown · BNDW
Technology100.0%

IBB top holdings

Top holdings · IBB
GILDGilead Sciences Inc8.94%
AMGNAmgen Inc8.31%
VRTXVertex Pharmaceuticals Inc7.87%
REGNRegeneron Pharmaceuticals Inc6.24%
MRNAModerna Inc5.49%
NTRANatera Inc3.78%
ARGXargenx SE ADR3.36%
BIIBBiogen Inc2.52%
RVMDRevolution Medicines Inc Ordinary Shares2.50%
ILMNIllumina Inc2.41%
Sector breakdown · IBB
Healthcare100.0%

About BNDW

BNDW (Vanguard Total World Bond ETF) is Total global bond market — US plus international. Managed by Vanguard, the fund carries $1.9B in assets under management, an expense ratio of 0.05%, a dividend yield of 4.36%. Its largest holding is Vanguard Total Bond Market ETF (BND), which represents 51.3% of the portfolio. Technology is the fund's largest sector exposure at 100.0%.

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.